Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Construction in Progress (2016)

Voyager Therapeutics (VYGR) has disclosed Construction in Progress for 1 consecutive years, with $3.0 million as the latest value for Q4 2016.

  • Quarterly Construction in Progress changed N/A to $3.0 million in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2016, changed N/A year-over-year, with the annual reading at $3.0 million for FY2016, N/A changed from the prior year.
  • Construction in Progress hit $3.0 million in Q4 2016 for Voyager Therapeutics.
  • In the past five years, Construction in Progress ranged from a high of $3.0 million in Q4 2016 to a low of $3.0 million in Q4 2016.